Susquehanna International Group Ltd. Oramed Pharmaceuticals Inc. Transaction History

Susquehanna International Group Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 16, 2023	BUY	$1.93 - $13.1 $219,105 - $1.49 Million	113,526 New	113,526 $247,000
Q1 2022 May 16, 2022	SELL	$8.19 - $13.89 $110,884 - $188,056	-13,539 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$12.98 - $29.75 $175,736 - $402,785	13,539 New	13,539 $178,000

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $92.4M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Susquehanna International Group Ltd., based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group Ltd. with notifications on news.